Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;14(1):121-133.
doi: 10.3233/JPD-230006.

Chronotropic Incompetence During Exercise Testing as a Marker of Autonomic Dysfunction in Individuals with Early Parkinson's Disease

Affiliations

Chronotropic Incompetence During Exercise Testing as a Marker of Autonomic Dysfunction in Individuals with Early Parkinson's Disease

Garett Griffith et al. J Parkinsons Dis. 2024.

Abstract

Background: An attenuated heart rate response to exercise, termed chronotropic incompetence, has been reported in Parkinson's disease (PD). Chronotropic incompetence may be a marker of autonomic dysfunction and a cause of exercise intolerance in early stages of PD.

Objective: To investigate the relationship between chronotropic incompetence, orthostatic blood pressure change (supine - standing), and exercise performance (maximal oxygen consumption, VO2peak) in individuals with early PD within 5 years of diagnosis not on dopaminergic medications.

Methods: We performed secondary analyses of heart rate and blood pressure data from the Study in Parkinson's Disease of Exercise (SPARX).

Results: 128 individuals were enrolled into SPARX (63.7±9.3 years; 57.0% male, 0.4 years since diagnosis [median]). 103 individuals were not taking chronotropic medications, of which 90 had a normal maximal heart rate response to exercise testing (155.3±14.0 bpm; PDnon-chrono) and 13 showed evidence of chronotropic incompetence (121.3±11.3 bpm; PDchrono, p < 0.05). PDchrono had decreased VO2peak compared to PDnon-chrono (19.7±4.5 mL/kg/min and 24.3±5.8 mL/kg/min, respectively, p = 0.027). There was a positive correlation between peak heart rate during exercise and the change in systolic blood pressure from supine to standing (r = 0.365, p < 0.001).

Conclusions: A subgroup of individuals with early PD not on dopaminergic medication had chronotropic incompetence and decreased VO2peak, which may be related to autonomic dysfunction. Evaluation of both heart rate responses to incremental exercise and orthostatic vital signs may serve as biomarkers of early autonomic impairment and guide treatment. Further studies should investigate whether cardiovascular autonomic dysfunction affects the ability to exercise and whether exercise training improves autonomic dysfunction.

Keywords: Exercise; Parkinson’s disease; autonomic nervous system; chronotropic incompetence; heart rate.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to report.

Figures

Fig. 1
Fig. 1
Association between age and maximal heart rate during CPET in SPARX by chronotropic group. PDnon-chrono (n = 90), PDchrono (n = 13), and PDchronomed (n = 25).
Fig. 2
Fig. 2
Maximal heart rate in each study group. Data are median, interquartile range, and 95% confidence interval. PDnon-chrono (n = 90), PDchrono (n = 13), and PDchronomed (n = 25). p < 0.001 for PDnon-chrono vs. PDchrono, p < 0.001 for PDnon-chrono vs. PDchronomed, p = 0.010 for PDchrono vs. PDchronomed.
Fig. 3
Fig. 3
Association between systolic orthostatic blood pressure response (i.e., standing-lying SBP) and deviation from APMHR in study participants. PDnon-chrono (n = 87), PDchrono (n = 13), and PDchronomed (n = 25).
Fig. 4
Fig. 4
A) Cardiorespiratory fitness as measured by VO2peak, p = 0.027 for PDnon-chrono vs. PDchrono (PDnon-chrono (n = 89), PDchrono (n = 13), and PDchronomed (n = 25)). B) peak respiratory exchange ratio, p = 0.448 (PDnon-chrono (n = 90), PDchrono (n = 13), and PDchronomed (n = 25). Data are median, interquartile range, and 95% confidence interval.

Similar articles

Cited by

References

    1. Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386, 896–912. - PubMed
    1. Coon EA (2020) Autonomic dysfunction in the synucleinopathies. Semin Neurol 40, 492–501. - PubMed
    1. Merola A, Romagnolo A, Rosso M, Suri R, Berndt Z, Maule S, Lopiano L, Espay A (2018) Autonomic dysfunction in Parkinson’s disease: A prospective cohort study. Mov Disord 33, 391–397. - PubMed
    1. Lamotte G, Lenka A (2022) Orthostatic hypotension in Parkinson disease: What is new? Neurol Clin Pract 12, e112–e115. - PMC - PubMed
    1. Sabino-Carvalho JL, Fisher J, Vianna L (2021) Autonomic function in patients with Parkinson’s disease: From rest to exercise. Front Physiol 12, 626–640. - PMC - PubMed

Publication types